NOVEOME BIOTHERAPEUTICS
Noveome Biotherapeutics is a clinical-stage company focusing on breakthrough therapies for the regenerative repair of inflamed or damaged tissues.
NOVEOME BIOTHERAPEUTICS
Industry:
Biotechnology Clinical Trials Health Care Life Science
Founded:
2000-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.noveome.com
Total Employee:
11+
Status:
Active
Contact:
(412)402-9914
Email Addresses:
[email protected]
Total Funding:
22.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Government of Pennsylvania
Government of Pennsylvania investment in Grant - Noveome Biotherapeutics
Official Site Inspections
http://www.noveome.com Semrush global rank: 3.48 M Semrush visits lastest month: 4.35 K
- Host name: 29.111.198.104.bc.googleusercontent.com
- IP address: 104.198.111.29
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Noveome Biotherapeutics"
Home - Noveome Biotherapeutics
Nov 16, 2022 · Noveome is advancing its ST266 biologic, a first-of-its-kind, multi-targeted secretome containing hundreds of biologically active proteins and other factors crucial to …See details»
Company - Noveome Biotherapeutics
Noveome is a clinical-stage biopharmaceutical company advancing ST266— a first-of-its-kind, multi-targeted secretome containing hundreds of biologically …See details»
Noveome Biotherapeutics - Crunchbase Company Profile & Funding
Noveome Biotherapeutics focuses on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. View contacts for Noveome Biotherapeutics to access new …See details»
Noveome Biotherapeutics, Inc. | LinkedIn
Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company, originally founded as...See details»
Science - Noveome Biotherapeutics
ST266 is a first-of-its-kind, multi-targeted, non-cellular novel biologic with the potential to improve patients’ outcomes across a range of challenging diseases and conditions in ophthalmology, neurology, dermatology—and more.See details»
ST266—a next-generation anti-inflammatory and
Noveome Biotherapeutics, Inc. is developing a new class of biologic consisting of the secretome of a novel population of cells derived from the amnion. Presently, the company is looking for...See details»
Noveome Biotherapeutics, Inc. Receives Rare Pediatric …
May 24, 2022 · Based in Pittsburgh, PA, Noveome Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation biologic therapeutics for the promotion and...See details»
Noveome Biotherapeutics, Inc. Announces Christopher …
May 24, 2021 · Based in Pittsburgh, Noveome Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular...See details»
Noveome Biotherapeutics | Biotech Careers
Noveome is advancing its ST266 platform biologic, a first-of-its-kind, multi-targeted secretome containing hundreds of biologically active proteins and other factors crucial to neuroprotection, …See details»
Noveome Biotherapeutics, Inc. Announces Preliminary Results of …
Jun 7, 2021 · Based in Pittsburgh, Noveome Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the …See details»
Pittsburgh’s Noveome Biotherapeutics closed $20.7M …
Aug 21, 2023 · Noveome Biotherapeutics is producing a treatment for necrotizing enterocolitis, a rare gastrointestinal disease that impacts pediatric patients. After years of development, the company’s cell-free platform biologic, ST266, is …See details»
Noveome Biotherapeutics, Inc. Announces New Appointments to …
Oct 22, 2020 · Noveome has launched a program to test its novel platform biologic, ST266, as a treatment for the severe inflammatory response seen in COVID-19 infection as well as the …See details»
Noveome Biothrerapeutics - VentureRadar
Noveome is advancing its ST266 platform biologic, a first-of-its-kind, multi-targeted secretome containing hundreds of biologically active proteins and other factors crucial to neuroprotection, …See details»
Noveome Biotherapeutics - Overview, News & Similar companies
Aug 21, 2023 · View Noveome Biotherapeutics (www.noveome.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar companies as well …See details»
Noveome Biotherapeutics, Inc. Announces New ... - Business Wire
Oct 22, 2020 · Noveome has launched a program to test its novel platform biologic, ST266, as a treatment for the severe inflammatory response seen in COVID-19 infection as well as the …See details»
Noveome Biotherapeutics - Products, Competitors, Financials, …
Noveome Biotherapeutics is a biopharmaceutical company. that focuses on developing biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues. It …See details»
Noveome Biotherapeutics, Inc. Commences Phase 1 Clinical Study …
Jun 23, 2021 · Noveome Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular …See details»
Press Releases - Noveome Biotherapeutics
Noveome Biotherapeutics, Inc. Announces Preliminary Results of its Phase 1 Open Label Clinical Trial Evaluating Intranasal Delivery of Lead Candidate ST266 In Glaucoma Suspect PatientsSee details»
Noveome Biotherapeutics: Navigating the Drug Development …
Noveome Biotherapeutics, a clinical-stage biopharmaceutical company, is making a substantial impact in this field by developing next-generation biologics that promote and restore cellular …See details»
Pipeline - Noveome Biotherapeutics
Noveome believes that its lead biologic drug candidate, ST266, has the potential to prevent or significantly reduce the life-threatening cytokine storm observed in severely ill COVID-19 …See details»